NOVO.B.DK

300.75

+3.48%↑

GMAB.DK

1,645.5

+0.37%↑

HLUNB.DK

42.46

-1.35%↓

ZEAL.DK

347

+0.7%↑

AMBUB.DK

62.05

-0.88%↓

NOVO.B.DK

300.75

+3.48%↑

GMAB.DK

1,645.5

+0.37%↑

HLUNB.DK

42.46

-1.35%↓

ZEAL.DK

347

+0.7%↑

AMBUB.DK

62.05

-0.88%↓

NOVO.B.DK

300.75

+3.48%↑

GMAB.DK

1,645.5

+0.37%↑

HLUNB.DK

42.46

-1.35%↓

ZEAL.DK

347

+0.7%↑

AMBUB.DK

62.05

-0.88%↓

NOVO.B.DK

300.75

+3.48%↑

GMAB.DK

1,645.5

+0.37%↑

HLUNB.DK

42.46

-1.35%↓

ZEAL.DK

347

+0.7%↑

AMBUB.DK

62.05

-0.88%↓

NOVO.B.DK

300.75

+3.48%↑

GMAB.DK

1,645.5

+0.37%↑

HLUNB.DK

42.46

-1.35%↓

ZEAL.DK

347

+0.7%↑

AMBUB.DK

62.05

-0.88%↓

Home・Listă Acțiuni・Coloplast A-S (Class B)

Coloplast A-S (Class B)

Închisă

400 -0.57

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

399.1

Maxim

403.7

Indicatori cheie
By Trading Economics
Venit	522M 1.4B
Vânzări	83M 7B
P/E Medie Sector	23.047 49.8
EPS	6.32
Randament dividend	5.71
Marjă de profit	19.835
Angajați	16,983
EBITDA	309M 2.3B

Recomandări
By TipRanks
Recomandări	Neutru
Prognoză pe 12 luni	+11.86% upside

Dividende
By Dow Jones
Randament dividend Medie Sector	5.71% 2.25%
Următoarele câștiguri	12 mai 2026
Data viitoare de dividende	20 mai 2026
Următoarea dată ex-dividende	18 mai 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-27B 92B
Deschiderea anterioară	400.57
Închiderea anterioară	400

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

11 mai 2026, 22:15 UTC

Achiziții, Fuziuni, Preluări

BMO Financial Group to Sell Transportation-, Vendor-Finance Businesses to Stonepeak

11 mai 2026, 23:46 UTC

Market Talk

Yen Consolidates as Traders Await Bessent's Meetings -- Market Talk

11 mai 2026, 23:44 UTC

Market Talk

Nikkei May Rise on AI Enthusiasm -- Market Talk

11 mai 2026, 23:33 UTC

Market Talk

Gold Rises on Possible Position Adjustments -- Market Talk

11 mai 2026, 22:37 UTC

Market Talk

CSL's Profit, Revenue Downgrade 'Not a Complete Surprise' -- Market Talk

11 mai 2026, 22:32 UTC

Câștiguri

Verde Clean Fuels 1Q Loss/Shr 5c >VGAS

11 mai 2026, 22:02 UTC

Market Talk

Evenimente importante

Stellar Auto Sales Increase in Canada Could Be Tied to Return of EV Incentives -- Market Talk

11 mai 2026, 21:49 UTC

Câștiguri

Rigetti Computing Revenue Triples. Why the Quantum Stock Is Falling. -- Barrons.com

11 mai 2026, 21:42 UTC

Market Talk

Declining Hours Worked Should Keep Bank of Canada Firmly on Hold -- Market Talk

11 mai 2026, 21:32 UTC

Achiziții, Fuziuni, Preluări

Bank of Montreal to Sell Transportation Finance and Vendor Finance Businesses to Stonepeak

11 mai 2026, 21:32 UTC

Achiziții, Fuziuni, Preluări

BMO: Supports Strategy to Elevate Returns and Accelerate Growth, Transaction Accretive to Cap Ratios and ROE >BMO.T

11 mai 2026, 21:32 UTC

Achiziții, Fuziuni, Preluări

BMO: Positions Businesses for Continued Growth in Efficient Cap Structure >BMO.T

11 mai 2026, 21:32 UTC

Achiziții, Fuziuni, Preluări

BMO: To Invest in 19.9% Equity Interest, Enabling Continued Participation in the Businesses' Long-Term Value Creation >BMO.T

11 mai 2026, 21:31 UTC

Achiziții, Fuziuni, Preluări

BMO: Announces Strategic Sale of Transportation and Vendor Finance Businesses

11 mai 2026, 21:23 UTC

Achiziții, Fuziuni, Preluări

CSG Systems Sale to NEC Gets CFIUS Clearance

11 mai 2026, 21:12 UTC

Câștiguri

Ovintiv: Full-Yr Production Volumes Expected to Avg 620 to 645 MBOE/d, Full-Yr Expected Cap Investment of $2.25B to $2.35B >OVV

11 mai 2026, 21:12 UTC

Câștiguri

Ovintiv 1Q Loss/Shr $2.35 >OVV

11 mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

11 mai 2026, 20:44 UTC

Câștiguri

Steris: Board Approves New $1B Shr Repurchase Program >STE

11 mai 2026, 20:43 UTC

Câștiguri

Whirlpool Shares Are Still Falling. Last Week's Earnings Might Be Why. -- Barrons.com

11 mai 2026, 20:32 UTC

Câștiguri

CleanSpark 2Q Loss/Shr $1.52 >CLSK

11 mai 2026, 20:32 UTC

Câștiguri

CleanSpark 2Q Rev $136.4M >CLSK

11 mai 2026, 20:30 UTC

Câștiguri

Hims & Hers Stock Sinks. Why Earnings Offered Wall Street a Big Surprise. -- Barrons.com

11 mai 2026, 20:30 UTC

Câștiguri

Steris 4Q Cont Ops EPS $2.24 >STE

11 mai 2026, 20:30 UTC

Câștiguri

Steris 4Q Rev $1.6B >STE

11 mai 2026, 20:30 UTC

Câștiguri

Steris Sees FY Adj EPS $11.10-Adj EPS $11.30 >STE

11 mai 2026, 20:30 UTC

Câștiguri

Steris 4Q Adj EPS $2.83 >STE

11 mai 2026, 20:22 UTC

Acțiuni populare

Stocks to Watch: Moderna, Intel, Micron, Fox -- WSJ

11 mai 2026, 19:37 UTC

Câștiguri

More Bad News at KKR's Private Credit Fund -- Barrons.com

11 mai 2026, 19:32 UTC

Market Talk

Oil Gains As Trump Rejects Iran's Response to U.S. Plan -- Market Talk

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK 11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 8 analiști care au acordat evaluări ale acțiunilor Coloplast A-S (Class B) - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.